Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Ovarian Neoplasms 24Neoplasms 10Fallopian Tube Neoplasms 7Breast Neoplasms 5Prostatic Neoplasms 4Pancreatic Neoplasms 3Neoplasm Metastasis 2Mesothelioma 2Carcinoma, Transitional Cell 2Carcinoma, Ovarian Epithelial 2Carcinoma, Non-Small-Cell Lung 2Uveal Melanoma 1Uterine Neoplasms 1Urothelial Cancer 1Urogenital Neoplasms 1Urinary Bladder Neoplasms 1Unilateral Breast Neoplasms 1Triple Negative Breast Neoplasms 1Solid Tumor 1Sarcoma, Ewing 1Recurrence 1Prostatic Diseases 1Prostate Carcinoma Metastatic to the Bone 1Prostate Adenocarcinoma 1Platinum-resistant Recurrent Clear Cell Ovarian Cancer 1Pancreatic Adenocarcinoma 1Ovarian Diseases 1Mesothelioma, Malignant 1Melanoma 1Leukemia, Prolymphocytic, T-Cell 1

Interventions

niraparib 1Watchful Waiting 1Surveys and Questionnaires 1Receptors, Bombesin 1Radiotherapy 1Radiosurgery 1Radiation Dose Hypofractionation 1Radiation 1Observation 1Neoadjuvant Therapy 1Magnetic Resonance Spectroscopy 1Gallium 1Estramustine 1Docetaxel 1Diet Therapy 1Cholecalciferol 1Carboplatin 1BAY 86-7548 1Adjuvants, Pharmaceutic 168Ga-bombesin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Prostate Adenocarcinoma × niraparib × Clear all
NCT04288687 2026-03-04

A Trial of Niraparib in Platinum-Sensitive Castration-Resistant Prostate Cancer With DNA Repair Defects

Abramson Cancer Center at Penn Medicine

Phase 2 Completed
11 enrolled 13 charts
Genitourinary

Prostate Adenocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡